URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Lisa Demeter

Concepts (278)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
HIV-1
66
1995
544
11.210
Why?
HIV Infections
46
1995
600
7.260
Why?
Anti-HIV Agents
35
1996
179
7.160
Why?
HIV Reverse Transcriptase
23
1995
110
4.540
Why?
Reverse Transcriptase Inhibitors
25
1995
87
4.480
Why?
Virus Replication
21
1992
287
4.150
Why?
Drug Resistance, Viral
21
2003
67
4.080
Why?
HIV Protease Inhibitors
11
1997
56
2.950
Why?
Mutation
21
1995
1183
2.470
Why?
Drug Monitoring
6
2003
39
2.390
Why?
Acquired Immunodeficiency Syndrome
10
1995
207
2.120
Why?
RNA, Viral
26
1990
274
2.100
Why?
Zidovudine
14
1995
69
1.870
Why?
Indinavir
8
1997
18
1.820
Why?
Drug Resistance, Microbial
14
1997
115
1.550
Why?
Ribonuclease H
5
1999
74
1.320
Why?
Delavirdine
6
1997
14
1.310
Why?
HIV
6
2001
73
1.250
Why?
Viral Load
15
1997
138
1.220
Why?
Benzoxazines
7
2003
34
1.180
Why?
Lamivudine
5
1997
27
1.160
Why?
DNA, Viral
12
1990
288
1.130
Why?
CD4 Lymphocyte Count
19
1995
147
1.130
Why?
Microbial Sensitivity Tests
8
1995
164
1.110
Why?
Humans
76
1990
35000
0.980
Why?
Recombination, Genetic
2
2004
173
0.930
Why?
Antiretroviral Therapy, Highly Active
7
2003
67
0.920
Why?
HIV Protease
3
2004
22
0.860
Why?
Papillomaviridae
7
1990
136
0.850
Why?
Dideoxynucleosides
3
2003
15
0.820
Why?
Drug Therapy, Combination
16
1995
375
0.780
Why?
RNA-Directed DNA Polymerase
2
1995
60
0.780
Why?
Tumor Virus Infections
4
1992
60
0.710
Why?
Adult
36
1990
10906
0.710
Why?
Piperazines
4
1995
71
0.710
Why?
Oxazines
3
2003
29
0.670
Why?
Cell Line
11
1999
1554
0.670
Why?
Genes, Viral
4
1998
88
0.630
Why?
Didanosine
3
1995
21
0.630
Why?
Mutagenesis, Site-Directed
5
2000
282
0.610
Why?
Flow Cytometry
2
2006
597
0.570
Why?
Female
39
1990
19061
0.570
Why?
Male
33
1990
18870
0.540
Why?
Models, Biological
3
2006
982
0.500
Why?
DNA Replication
1
2006
189
0.490
Why?
Gene Products, gag
1
2004
17
0.480
Why?
Genome, Viral
1
2004
34
0.470
Why?
Genotype
10
1998
455
0.470
Why?
Leukocytes, Mononuclear
2
1998
109
0.460
Why?
Antiviral Agents
4
1995
181
0.440
Why?
Sequence Analysis, DNA
3
1998
161
0.430
Why?
Middle Aged
16
1993
9461
0.420
Why?
Treatment Outcome
10
1996
2487
0.410
Why?
AIDS-Related Opportunistic Infections
1
2002
54
0.400
Why?
Base Sequence
7
1995
1681
0.390
Why?
Mutation, Missense
3
2010
81
0.380
Why?
Pneumonia, Pneumocystis
1
2002
118
0.370
Why?
Phenotype
7
1997
727
0.370
Why?
Laboratories
2
1998
25
0.360
Why?
Tyrosine
1
2001
133
0.350
Why?
HIV Envelope Protein gp120
1
2000
46
0.350
Why?
Cysteine
1
2001
153
0.350
Why?
Cells, Cultured
8
1992
2367
0.340
Why?
Defective Viruses
1
1999
14
0.330
Why?
Interferon-gamma
4
2000
340
0.320
Why?
Uterine Cervical Neoplasms
2
1992
125
0.310
Why?
Kinetics
4
1999
1377
0.310
Why?
Papillomavirus Infections
2
1994
45
0.300
Why?
Carcinoma in Situ
2
1992
41
0.280
Why?
Anti-Retroviral Agents
3
2003
25
0.270
Why?
Condylomata Acuminata
5
1990
52
0.270
Why?
Indoles
1
1997
93
0.270
Why?
Nelfinavir
3
2003
7
0.260
Why?
Reagent Kits, Diagnostic
2
2004
17
0.260
Why?
HIV Core Protein p24
3
1998
28
0.250
Why?
Carcinoma, Squamous Cell
2
1992
230
0.240
Why?
Papilloma
1
1994
13
0.230
Why?
Drug Administration Schedule
3
2009
362
0.230
Why?
Prevalence
3
1993
530
0.230
Why?
Clinical Trials as Topic
3
2000
664
0.230
Why?
Double-Blind Method
6
1990
985
0.220
Why?
Penile Neoplasms
1
1993
16
0.220
Why?
Keratinocytes
1
1994
105
0.220
Why?
Antigens, Neoplasm
1
1994
105
0.220
Why?
Codon
3
1998
69
0.210
Why?
Treatment Failure
4
2000
125
0.210
Why?
Point Mutation
2
1999
169
0.200
Why?
Molecular Sequence Data
4
1995
1993
0.200
Why?
Receptors, Immunologic
1
1992
49
0.200
Why?
Follow-Up Studies
4
1990
1757
0.190
Why?
Virus Cultivation
2
1992
30
0.190
Why?
HeLa Cells
2
1999
291
0.190
Why?
Computer Simulation
2
2008
295
0.180
Why?
CD8-Positive T-Lymphocytes
2
1997
223
0.180
Why?
5' Untranslated Regions
2
1999
23
0.180
Why?
Virology
1
2010
22
0.180
Why?
Sensitivity and Specificity
4
2003
866
0.180
Why?
HIV Envelope Protein gp41
1
2010
4
0.180
Why?
Nuclear Proteins
1
1994
333
0.170
Why?
Virulence
1
2010
152
0.170
Why?
Virus Latency
1
2010
14
0.170
Why?
Virion
1
2010
63
0.170
Why?
Pregnancy Complications, Infectious
3
1995
82
0.170
Why?
Linear Models
2
2006
228
0.160
Why?
Software
1
2010
126
0.160
Why?
Internet
1
2010
92
0.160
Why?
Polymerase Chain Reaction
5
1997
586
0.160
Why?
Virus Physiological Phenomena
1
2008
5
0.160
Why?
T-Lymphocytes
3
2001
546
0.150
Why?
CD4-Positive T-Lymphocytes
2
1997
299
0.150
Why?
Reproducibility of Results
3
1998
859
0.150
Why?
Biometry
1
2008
42
0.150
Why?
Peptide Fragments
1
2010
277
0.150
Why?
Antigens, Fungal
2
2002
35
0.150
Why?
Lymphocyte Count
2
1997
52
0.150
Why?
RNA, Transfer, Amino Acyl
2
2001
13
0.140
Why?
Mice, SCID
1
2007
170
0.140
Why?
Stavudine
2
1997
5
0.140
Why?
Cervical Intraepithelial Neoplasia
1
2006
26
0.130
Why?
Developing Countries
1
2006
40
0.130
Why?
Mice
3
1992
5900
0.130
Why?
RNA, Transfer, Lys
1
2006
11
0.130
Why?
Pregnancy
5
1995
1919
0.130
Why?
Antigens, Thy-1
1
2006
59
0.130
Why?
Mathematics
1
2006
149
0.130
Why?
Animals
4
1992
15647
0.130
Why?
Interferons
2
1996
46
0.130
Why?
Research Design
1
2008
326
0.130
Why?
Amino Acid Substitution
1
2006
118
0.130
Why?
Genes, Reporter
1
2006
206
0.130
Why?
T-Lymphocytes, Cytotoxic
1
2006
130
0.120
Why?
DNA Primers
1
2006
401
0.120
Why?
RNA, Messenger
1
1992
1791
0.120
Why?
Nucleosides
1
2004
11
0.120
Why?
Templates, Genetic
1
2004
74
0.120
Why?
Disease Progression
3
1997
496
0.120
Why?
Cercopithecus aethiops
1
2004
154
0.110
Why?
COS Cells
1
2004
158
0.110
Why?
Sequence Alignment
1
2004
197
0.110
Why?
Adenine
1
2003
45
0.110
Why?
Retrospective Studies
4
1995
2167
0.110
Why?
Aged
4
1999
6986
0.110
Why?
Cloning, Molecular
1
2004
495
0.110
Why?
Mutagenesis
2
1999
130
0.110
Why?
Oncogene Proteins, Viral
2
1992
47
0.110
Why?
DNA, Fungal
1
2002
83
0.100
Why?
Proviruses
2
1997
9
0.100
Why?
Pneumocystis
1
2002
101
0.100
Why?
Clinical Protocols
1
2001
102
0.100
Why?
Vaccines, DNA
1
2001
22
0.090
Why?
Papillomavirus Vaccines
1
2001
18
0.090
Why?
Adenosine
1
2001
86
0.090
Why?
3' Untranslated Regions
1
2001
32
0.090
Why?
Hydrolysis
1
2001
138
0.090
Why?
Heteroduplex Analysis
1
2000
3
0.090
Why?
Dehydroepiandrosterone Sulfate
1
2000
7
0.090
Why?
Practice Guidelines as Topic
1
2003
288
0.090
Why?
Sequence Analysis
1
2000
26
0.090
Why?
Viral Vaccines
1
2001
107
0.090
Why?
Guidelines as Topic
1
2001
87
0.090
Why?
Predictive Value of Tests
1
2002
579
0.090
Why?
Autonomic Nervous System
1
2000
69
0.090
Why?
Evolution, Molecular
1
2000
64
0.090
Why?
Logistic Models
1
2001
581
0.080
Why?
Gene Amplification
1
1998
28
0.080
Why?
Drug Eruptions
1
1998
28
0.080
Why?
Drug Resistance
2
1995
97
0.080
Why?
Specimen Handling
2
2006
70
0.080
Why?
Interferon-alpha
2
1990
84
0.070
Why?
Immunotherapy
1
1997
88
0.070
Why?
Cell Proliferation
2
2008
480
0.070
Why?
Cohort Studies
1
1998
912
0.060
Why?
Biopsy
1
1996
359
0.060
Why?
Infectious Disease Transmission, Vertical
1
1995
45
0.060
Why?
Genital Neoplasms, Male
1
1994
15
0.060
Why?
Genital Neoplasms, Female
1
1994
33
0.060
Why?
Laryngeal Neoplasms
1
1994
18
0.060
Why?
Proliferating Cell Nuclear Antigen
1
1994
48
0.060
Why?
Immunoenzyme Techniques
1
1994
220
0.050
Why?
Regression Analysis
3
1990
489
0.050
Why?
Virus Integration
1
1993
23
0.050
Why?
Blotting, Southern
1
1993
103
0.050
Why?
In Situ Hybridization
1
1994
293
0.050
Why?
Area Under Curve
2
2000
61
0.050
Why?
Vaginal Smears
2
1999
69
0.050
Why?
Receptors, Laminin
1
1992
7
0.050
Why?
Warts
1
1992
23
0.050
Why?
Patient Selection
2
2003
197
0.050
Why?
Nucleic Acid Hybridization
1
1992
176
0.050
Why?
Pyridazines
1
2011
7
0.050
Why?
Nevirapine
1
2011
8
0.050
Why?
Neoplasm Invasiveness
1
1992
150
0.050
Why?
Blotting, Northern
1
1992
289
0.050
Why?
RNA, Complementary
1
2010
13
0.050
Why?
Antigens, Bacterial
1
2011
96
0.050
Why?
Antigens, Viral
1
2011
151
0.050
Why?
Interferon Type I
1
1990
39
0.040
Why?
Calibration
1
2010
44
0.040
Why?
Ribonuclease H, Human Immunodeficiency Virus
1
2010
2
0.040
Why?
Quality Control
1
2010
72
0.040
Why?
Drug Resistance, Multiple, Viral
1
2010
6
0.040
Why?
Selection, Genetic
1
2010
14
0.040
Why?
Placebos
1
2010
177
0.040
Why?
Viremia
1
2009
26
0.040
Why?
Cell Division
1
1992
735
0.040
Why?
Adolescent
2
1993
4513
0.040
Why?
Statistics, Nonparametric
1
2010
251
0.040
Why?
New York
2
1999
1191
0.040
Why?
Least-Squares Analysis
1
2008
28
0.040
Why?
Nonlinear Dynamics
1
2008
35
0.040
Why?
Monte Carlo Method
1
2008
57
0.040
Why?
Acute Disease
1
2009
570
0.040
Why?
Ritonavir
1
2007
13
0.040
Why?
Lopinavir
1
2007
15
0.040
Why?
Safety
2
1995
99
0.040
Why?
Infant, Newborn
2
1995
1772
0.040
Why?
Developed Countries
1
2006
5
0.030
Why?
Pyrimidinones
1
2007
20
0.030
Why?
Young Adult
1
2010
1013
0.030
Why?
Maternal-Fetal Exchange
1
2006
139
0.030
Why?
Fibroblasts
2
1992
514
0.030
Why?
Herpesvirus 4, Human
1
2006
61
0.030
Why?
Cytomegalovirus
1
2006
77
0.030
Why?
Prospective Studies
1
2009
1606
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
459
0.030
Why?
Algorithms
1
2008
518
0.030
Why?
Pharmacogenetics
1
2003
10
0.030
Why?
Peptides
1
2006
277
0.030
Why?
Vesicular stomatitis Indiana virus
1
2003
12
0.030
Why?
Chronic Disease
1
2006
496
0.030
Why?
HIV Seropositivity
1
2003
32
0.030
Why?
Protease Inhibitors
1
2003
42
0.030
Why?
Transcription, Genetic
2
1992
795
0.030
Why?
Health Planning Guidelines
1
2003
21
0.030
Why?
HLA Antigens
1
2003
91
0.030
Why?
Patient Compliance
1
2003
170
0.030
Why?
Recurrence
2
1990
656
0.020
Why?
Methylation
1
2001
51
0.020
Why?
Interleukin-5
1
2001
41
0.020
Why?
Capsid Proteins
1
2001
33
0.020
Why?
beta 2-Microglobulin
1
2000
20
0.020
Why?
Species Specificity
1
2001
335
0.020
Why?
Th1 Cells
1
2000
72
0.020
Why?
Polyneuropathies
1
2000
41
0.020
Why?
Th2 Cells
1
2000
89
0.020
Why?
Respiration
1
2000
176
0.020
Why?
Risk Assessment
1
2003
808
0.020
Why?
Interleukin-4
1
2000
160
0.020
Why?
Europe
1
1999
74
0.020
Why?
Outpatient Clinics, Hospital
1
1999
36
0.020
Why?
Cervix Uteri
1
1999
65
0.020
Why?
Lymphocyte Activation
1
2001
407
0.020
Why?
World Health
1
1999
59
0.020
Why?
Sex Characteristics
1
2000
138
0.020
Why?
Antibodies, Viral
1
2001
472
0.020
Why?
Transfection
1
2001
833
0.020
Why?
Heart Rate
1
2000
449
0.020
Why?
Cognition Disorders
1
2000
262
0.020
Why?
Vaccines, Synthetic
1
1997
89
0.020
Why?
Cross-Sectional Studies
1
1999
627
0.020
Why?
Cryosurgery
1
1996
38
0.020
Why?
Dose-Response Relationship, Drug
1
1999
1085
0.020
Why?
United States
1
2003
2511
0.020
Why?
Longitudinal Studies
1
1997
372
0.020
Why?
Combined Modality Therapy
1
1996
459
0.020
Why?
Prognosis
1
1996
1030
0.010
Why?
3T3 Cells
1
1992
69
0.010
Why?
Epithelium
1
1992
223
0.010
Why?
Bisexuality
1
1990
10
0.010
Why?
Homosexuality
1
1990
22
0.010
Why?
Injections, Subcutaneous
1
1990
89
0.010
Why?
Epithelial Cells
1
1992
324
0.010
Why?
Infant
1
1995
2102
0.010
Why?
Risk Factors
1
1996
2172
0.010
Why?
Sex Factors
1
1990
561
0.010
Why?
Recombinant Proteins
1
1990
706
0.010
Why?
Time Factors
1
1995
3047
0.010
Why?
Cell Differentiation
1
1992
1021
0.010
Why?

Visualizations


Demeter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department